Western University of Health Sciences Graduate College of Biomedical Sciences Western University of Health Sciences
Graduate College of Biomedical Sciences

Betageri Lab

 

Dr. Betageri is well-recognized for his research in
the development and evaluation of liposomal and proliposomal drug delivery
systems and his research has led to numerous articles, book chapters as well as
a book. Dr. Betageri is considered one of the top researchers and experts in
this particular area of drug delivery. Besides his research papers, he has over
130 research presentations and abstracts with most presented at the top
national and international pharmaceutical meetings. Due to his recognition as
an expert in novel and traditional dosage forms, he has had opportunities to
obtain funding from both small and large pharmaceutical companies. Dr. Betageri
has done excellent work for these companies and they continue to seek his
advice and assistance. Further evidence of his stature is the large number of
invited lectures that he has presented at various pharmaceutical companies,
national and international symposiums in several countries including, China,
Germany, India, Japan, Poland, and US. He has an outstanding number of
publications (70+) which have appeared in some of the best pharmaceutical
research journals.

Formulation
Capabilities:
 

Formulation and
Development of Conventional and Novel Dosage forms and Drug Delivery Systems:

I. Conventional:

II. Novel:

  • Tablets
  • Capsules
  • Solutions
  • Suspensions
  • Emulsions
  • Ointments
  • Suppositories
  • Injectables (including
    lyophilization)

Liposomes

Proliposomes

Microspheres

Nanospheres

 

Recent Publications:

  1. S.
    Chopra, N. Venkatesan and G.V. Betageri. Formulation of lipid bearing pellets
    as a delivery system for poorly soluble drugs. Int. J. Pharm. 446: 136-144, 2013.
  2. S.
    Chopra, N. Venkatesan and G.V. Betageri. Liposomes as nanocarriers for anti-HIV
    therapy. Drug Delivery and Translational Research. (Accepted for publication)
    2013.
  3. K.
    Muppidi, A. S. Pumerantz, G. Betageri, J. Wang.  Development and validation of a rapid
    high-performance liquid chromatography method with UV detection for the
    determination of vancomycin in mouse plasma. Chrom. Sep. Tech. (Accepted for
    publication) 2013.
  4. K. Muppidi, A. Pumerantz, J. Wang, and G. V. Betageri. Development
    and stability studies of novel vancomycin formulations. ISRN Pharmaceutics.
    1-8, 2012.
  5. V.
    G. Kadajji and G. V. Betageri. Water soluble polymers for pharmaceutical
    applications. Polymer Sci. 3: 1972-2009, 2011.
  6. V.G.
    Kadajji, N. Venkatesan and G. V. Betageri. Approaches for dissolution testing
    of novel drug delivery systems. Pharm. Rev. 38-42, 2011.
  7. K.
    Muppidi, J. Wang, G. V. Betageri and A. S. Pumerantz. PEGylated Liposome
    Encapsulation Increases the Lung Tissue Concentration of Vancomycin. Antimicrb.
    Agents Chemother. 55: 4537-4542, 2011.
  8. A.
    Pumerantz, K. Muppidi, S. Agnihotri, C. Guerra, V. Venketaraman, J. Wang, G. V.
    Betageri. Liposomal vancomycin: Preparation and intracellular
    killing of MRSA. Int. J. Antimicrb. Agents. 37: 140-144, 2011.
  9. S.
    A. Agnihotri, K.S. Soppimath and G. V. Betageri. Controlled release application
    of multilamellar vesicles: A novel drug delivery approach. Drug Del. 17:
    92-101, 2010.
  10. D.
    Deshmukh, R. Nagilla, W. R. Ravis and G.V. Betageri. Effect of dodecylmaltoside
    (DDM) on uptake of BCS III compounds, tiludronate and cromolyn, in Caco-2 cells
    and rat intestinal model. Drug Del. 17: 145-151, 2010.

 

Patents

Country

Patent  No.

Title

Issue Date

Expiration Date

US

6,759,058

ENTERIC-COATED
PROLIPOSOMAL FORMULATIONS FOR POORLY WATER SOLUBLE DRUGS

7/6/2004

08/16/2021

US

6,849,269

PROLIPOSOMAL
DRUG DELIVERY SYSTEM

2/1/2005

08/16/2021

Japan

440515       (App 2002-

582880)

PROLIPOSOMAL
DRUG DELIVERY SYSTEM

11/13/2009

4/24/2022

India

233635

PROLIPOSOMAL
DRUG DELIVERY SYSTEM

4/24/2009

4/24/2022

Australia

AU2002256353

PROLIPOSOMAL
DRUG DELIVERY SYSTEM

4/24/2002

4/24/2022

 

View Dr. Betageri’s biographical information here